Walker EA, Picker MJ, Granger AL, Dykstra LA. Effects of opioids in morphine-treated pigeons trained to discriminate among morphine, the low-efficacy agonist nalbuphine, and saline. J Pharmacol Exp Ther. 2004 Jul;310(1):150-8.
Allen RM, Granger AL, Dykstra LA. The competitive N-methyl-D-aspartate receptor antagonist (-)-6-phosphonomethyl-deca-hydroisoquinoline-3-carboxylic acid (LY235959) potentiates the antinociceptive effects of opioids that vary in efficacy at the mu-opioid receptor. J Pharmacol Exp Ther. 2003 Nov 1;307(2):785-92.
Allen RM, Granger AL, Dykstra LA. Dextromethorphan potentiates the antinociceptive effects of morphine and the delta-opioid agonist SNC80 in squirrel monkeys. J Pharmacol Exp Ther. 2002 Feb 1;300(2):435-41.
Pendelton RG, Cook PG, Shepherd-Rose A, Mangel AW. Effects of H2-receptor antagonists upon physiological acid secretory states in animals. J Pharmacol Exp Ther. 1985 Apr;233(1):64-9.
Williams M, Martin GE, Remy DC, Hichens M, Mangel AW, Taylor DA, Yarbrough GG, Bendesky RJ, King SW, Robinson JL. L-646,462, a cyproheptadine-related antagonist of dopamine and serotonin with selectivity for peripheral systems. J Pharmacol Exp Ther. 1984 Jun 1;229(3):775-81.